Empery Asset Management’s iSpecimen ISPC Stock Holding History

Empery Asset Management’s Portfolio ISPC Stock Details ISPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-583	Closed	-$3.64M	–	80
2021 Q4	$3.64M	Buy	+583	New	+$4.18M	7.6%	3

Other funds holding ISPC

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Empery Asset Management's ISPC Position: Q1 2022 in Review

Empery Asset Management sold out of iSpecimen (ISPC) in Q1 2022, closing a stake of 583 shares — an estimated $3.64M sold.

Empery Asset Management first reported a position in ISPC in Q4 2021 and held it in 1 quarter. The position peaked at $3.64M in Q4 2021. 12 funds tracked by Wall St. Rank hold ISPC as of Q1 2022.

Empery Asset Management reported no remaining iSpecimen position as of Q1 2022 after selling out during the quarter.
Empery Asset Management sold 583 iSpecimen shares in Q1 2022, an estimated $3.64M.
Empery Asset Management first reported a position in iSpecimen in Q4 2021 and held it in 1 quarter.
Empery Asset Management's iSpecimen position peaked at $3.64M in Q4 2021.
12 funds tracked by Wall St. Rank held iSpecimen as of Q1 2022.

Based on Empery Asset Management's 13F filing for Q1 2022, filed 16 May 2022.